Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Safety and Pharmacokinetics of Once-Daily Topical Solution in Male Subjects With Androgenetic Alopecia

NCT05864885 is registered in ClinicalTrials.gov with Aneira Pharma, Inc. as lead sponsor.

NCT NCT05864885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05864885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Safety and Pharmacokinetics of Once-Daily Topical Solution in Male Subjects With Androgenetic Alopecia
Lead sponsor
Aneira Pharma, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
June 9, 2023
Completion date
July 17, 2023
Enrollment
14 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia